Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease
Shijun Yan(University of Oxford), George K. Tofaris(University of Oxford), Wolfgang H. Oertel(Philipps University of Marburg), Thomas R. Barber(University of Oxford), Michael Sommerauer(Forschungszentrum Jülich), Jason J. Davis(University of Oxford), Kenneth Marek(University of Pennsylvania), Aline Seger(Forschungszentrum Jülich), Cheng Jiang(Shenzhen Institute of Information Technology), Annette Janzen(Philipps University of Marburg)
Cited by 114
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846